Profile
Jenny Chaplin worked as the Vice President-Strategic Operations at Bellicum Pharmaceuticals, Inc. from 2018 to 2023.
Prior to that, she had no other former jobs.
Ms. Chaplin obtained her undergraduate degree from the University of the Witwatersrand.
Former positions of Jenny Chaplin
| Companies | Position | End |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-04-30 |
Training of Jenny Chaplin
| University of the Witwatersrand | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Jenny Chaplin
